View in EDS

Plasmodium falciparum reticulocyte-binding homologues are targets of human inhibitory antibodies and play a role in immune evasion

Saved in:
Bibliographic Details
Title: Plasmodium falciparum reticulocyte-binding homologues are targets of human inhibitory antibodies and play a role in immune evasion
Authors: Reiling, Linda, Persson, Kristina E.M., McCallum, Fiona J., Gicheru, Nimmo, Kinyanjui, Samson M., Chitnis, Chetan E., Fowkes, Freya J.I., Marsh, Kevin, Beeson, James G.
Contributors: Lund University, Faculty of Medicine, Department of Clinical Sciences, Lund, Infect@LU, Lunds universitet, Medicinska fakulteten, Institutionen för kliniska vetenskaper, Lund, Infect@LU, Originator, Lund University, Faculty of Medicine, Department of Laboratory Medicine, Division of Clinical Chemistry and Pharmacology, Malaria and Babesia, Lunds universitet, Medicinska fakulteten, Institutionen för laboratoriemedicin, Avdelningen för klinisk kemi och farmakologi, Malaria och Babesia, Originator, Lund University, Faculty of Medicine, Department of Laboratory Medicine, Division of Clinical Chemistry and Pharmacology, Lunds universitet, Medicinska fakulteten, Institutionen för laboratoriemedicin, Avdelningen för klinisk kemi och farmakologi, Originator
Source: Frontiers in Immunology. 16
Subject Terms: Medical and Health Sciences, Basic Medicine, Immunology in the Medical Area (including Cell and Immunotherapy), Medicin och hälsovetenskap, Medicinska och farmaceutiska grundvetenskaper, Immunologi inom det medicinska området (Här ingår: Cell- och immunterapi)
Description: Introduction: Antibodies targeting the blood-stage of Plasmodium falciparum play a critical role in naturally acquired immunity to malaria by limiting blood-stage parasitemia. One mode of action of antibodies is the direct inhibition of merozoite invasion of erythrocytes through targeting invasion ligands. However, evasion of inhibitory antibodies may be mediated in P. falciparum by switching between various ligand-mediated merozoite invasion pathways. Here, we investigated the potential roles of invasion ligands PfRH1, PfRH2a and PfRH2b in immune evasion through phenotypic variation, and their importance as targets of human invasion-inhibitory antibodies. Methods: Serum samples from malaria-exposed children and adults in Kenya were examined for their ability to inhibit P. falciparum invasion, using parasites with disrupted pfrh1, pfrh2a or pfrh2b genes. Results and Discussion: The loss of PfRH1 and PfRH2b substantially impacted on susceptibility to inhibitory antibodies, suggesting that variation in the use of these ligands contributes to immune evasion. The effect was less prominent with loss of PfRH2a. Differential inhibition of the knockout and parental lines points to PfRH1 and PfRH2b as targets of acquired growth inhibitory antibodies whereas PfRH2a appeared to be a minor target. There was limited relatedness of the inhibitory responses between different isolates or compared to parasites with deletions of erythrocyte-binding antigens. This further suggests that there is a substantial amount of antigenic diversity in invasion pathways to facilitate immune evasion. These findings provide evidence that PfRH1 and PfRH2b are significant targets of inhibitory antibodies and variation in their expression may facilitate immune evasion. Targeting of multiple invasion ligands in vaccine design is likely to be required to achieve potent inhibitory antibodies and protective efficacy against malaria.
Access URL: https://doi.org/10.3389/fimmu.2025.1532451
Database: SwePub
FullText Text:
  Availability: 0
CustomLinks:
  – Url: https://doi.org/10.3389/fimmu.2025.1532451#
    Name: EDS - SwePub (s4221598)
    Category: fullText
    Text: View record in SwePub
  – Url: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&db=pmc&term=1664-3224[TA]+AND+[PG]+AND+2025[PDAT]
    Name: FREE - PubMed Central (ISSN based link)
    Category: fullText
    Text: Full Text
    Icon: https://imageserver.ebscohost.com/NetImages/iconPdf.gif
    MouseOverText: Check this PubMed for the article full text.
  – Url: https://resolver.ebscohost.com/openurl?sid=EBSCO:edsswe&genre=article&issn=16643224&ISBN=&volume=16&issue=&date=20250101&spage=&pages=&title=Frontiers in Immunology&atitle=Plasmodium%20falciparum%20reticulocyte-binding%20homologues%20are%20targets%20of%20human%20inhibitory%20antibodies%20and%20play%20a%20role%20in%20immune%20evasion&aulast=Reiling%2C%20Linda&id=DOI:10.3389/fimmu.2025.1532451
    Name: Full Text Finder
    Category: fullText
    Text: Full Text Finder
    Icon: https://imageserver.ebscohost.com/branding/images/FTF.gif
    MouseOverText: Full Text Finder
  – Url: https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=EBSCO&SrcAuth=EBSCO&DestApp=WOS&ServiceName=TransferToWoS&DestLinkType=GeneralSearchSummary&Func=Links&author=Reiling%20L
    Name: ISI
    Category: fullText
    Text: Nájsť tento článok vo Web of Science
    Icon: https://imagesrvr.epnet.com/ls/20docs.gif
    MouseOverText: Nájsť tento článok vo Web of Science
Header DbId: edsswe
DbLabel: SwePub
An: edsswe.oai.portal.research.lu.se.publications.1d72e37f.6640.412c.9787.12b483d89bf1
RelevancyScore: 1065
AccessLevel: 6
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 1064.736328125
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Plasmodium falciparum reticulocyte-binding homologues are targets of human inhibitory antibodies and play a role in immune evasion
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AR" term="%22Reiling%2C+Linda%22">Reiling, Linda</searchLink><br /><searchLink fieldCode="AR" term="%22Persson%2C+Kristina+E%2EM%2E%22">Persson, Kristina E.M.</searchLink><br /><searchLink fieldCode="AR" term="%22McCallum%2C+Fiona+J%2E%22">McCallum, Fiona J.</searchLink><br /><searchLink fieldCode="AR" term="%22Gicheru%2C+Nimmo%22">Gicheru, Nimmo</searchLink><br /><searchLink fieldCode="AR" term="%22Kinyanjui%2C+Samson+M%2E%22">Kinyanjui, Samson M.</searchLink><br /><searchLink fieldCode="AR" term="%22Chitnis%2C+Chetan+E%2E%22">Chitnis, Chetan E.</searchLink><br /><searchLink fieldCode="AR" term="%22Fowkes%2C+Freya+J%2EI%2E%22">Fowkes, Freya J.I.</searchLink><br /><searchLink fieldCode="AR" term="%22Marsh%2C+Kevin%22">Marsh, Kevin</searchLink><br /><searchLink fieldCode="AR" term="%22Beeson%2C+James+G%2E%22">Beeson, James G.</searchLink>
– Name: Author
  Label: Contributors
  Group: Au
  Data: Lund University, Faculty of Medicine, Department of Clinical Sciences, Lund, Infect@LU, Lunds universitet, Medicinska fakulteten, Institutionen för kliniska vetenskaper, Lund, Infect@LU, Originator<br />Lund University, Faculty of Medicine, Department of Laboratory Medicine, Division of Clinical Chemistry and Pharmacology, Malaria and Babesia, Lunds universitet, Medicinska fakulteten, Institutionen för laboratoriemedicin, Avdelningen för klinisk kemi och farmakologi, Malaria och Babesia, Originator<br />Lund University, Faculty of Medicine, Department of Laboratory Medicine, Division of Clinical Chemistry and Pharmacology, Lunds universitet, Medicinska fakulteten, Institutionen för laboratoriemedicin, Avdelningen för klinisk kemi och farmakologi, Originator
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <i>Frontiers in Immunology</i>. 16
– Name: Subject
  Label: Subject Terms
  Group: Su
  Data: <searchLink fieldCode="DE" term="%22Medical+and+Health+Sciences%22">Medical and Health Sciences</searchLink><br /><searchLink fieldCode="DE" term="%22Basic+Medicine%22">Basic Medicine</searchLink><br /><searchLink fieldCode="DE" term="%22Immunology+in+the+Medical+Area+%28including+Cell+and+Immunotherapy%29%22">Immunology in the Medical Area (including Cell and Immunotherapy)</searchLink><br /><searchLink fieldCode="DE" term="%22Medicin+och+hälsovetenskap%22">Medicin och hälsovetenskap</searchLink><br /><searchLink fieldCode="DE" term="%22Medicinska+och+farmaceutiska+grundvetenskaper%22">Medicinska och farmaceutiska grundvetenskaper</searchLink><br /><searchLink fieldCode="DE" term="%22Immunologi+inom+det+medicinska+området+%28Här+ingår%3A+Cell-+och+immunterapi%29%22">Immunologi inom det medicinska området (Här ingår: Cell- och immunterapi)</searchLink>
– Name: Abstract
  Label: Description
  Group: Ab
  Data: Introduction: Antibodies targeting the blood-stage of Plasmodium falciparum play a critical role in naturally acquired immunity to malaria by limiting blood-stage parasitemia. One mode of action of antibodies is the direct inhibition of merozoite invasion of erythrocytes through targeting invasion ligands. However, evasion of inhibitory antibodies may be mediated in P. falciparum by switching between various ligand-mediated merozoite invasion pathways. Here, we investigated the potential roles of invasion ligands PfRH1, PfRH2a and PfRH2b in immune evasion through phenotypic variation, and their importance as targets of human invasion-inhibitory antibodies. Methods: Serum samples from malaria-exposed children and adults in Kenya were examined for their ability to inhibit P. falciparum invasion, using parasites with disrupted pfrh1, pfrh2a or pfrh2b genes. Results and Discussion: The loss of PfRH1 and PfRH2b substantially impacted on susceptibility to inhibitory antibodies, suggesting that variation in the use of these ligands contributes to immune evasion. The effect was less prominent with loss of PfRH2a. Differential inhibition of the knockout and parental lines points to PfRH1 and PfRH2b as targets of acquired growth inhibitory antibodies whereas PfRH2a appeared to be a minor target. There was limited relatedness of the inhibitory responses between different isolates or compared to parasites with deletions of erythrocyte-binding antigens. This further suggests that there is a substantial amount of antigenic diversity in invasion pathways to facilitate immune evasion. These findings provide evidence that PfRH1 and PfRH2b are significant targets of inhibitory antibodies and variation in their expression may facilitate immune evasion. Targeting of multiple invasion ligands in vaccine design is likely to be required to achieve potent inhibitory antibodies and protective efficacy against malaria.
– Name: URL
  Label: Access URL
  Group: URL
  Data: <link linkTarget="URL" linkTerm="https://doi.org/10.3389/fimmu.2025.1532451" linkWindow="_blank">https://doi.org/10.3389/fimmu.2025.1532451</link>
PLink https://erproxy.cvtisr.sk/sfx/access?url=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=edsswe&AN=edsswe.oai.portal.research.lu.se.publications.1d72e37f.6640.412c.9787.12b483d89bf1
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.3389/fimmu.2025.1532451
    Languages:
      – Text: English
    Subjects:
      – SubjectFull: Medical and Health Sciences
        Type: general
      – SubjectFull: Basic Medicine
        Type: general
      – SubjectFull: Immunology in the Medical Area (including Cell and Immunotherapy)
        Type: general
      – SubjectFull: Medicin och hälsovetenskap
        Type: general
      – SubjectFull: Medicinska och farmaceutiska grundvetenskaper
        Type: general
      – SubjectFull: Immunologi inom det medicinska området (Här ingår: Cell- och immunterapi)
        Type: general
    Titles:
      – TitleFull: Plasmodium falciparum reticulocyte-binding homologues are targets of human inhibitory antibodies and play a role in immune evasion
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Reiling, Linda
      – PersonEntity:
          Name:
            NameFull: Persson, Kristina E.M.
      – PersonEntity:
          Name:
            NameFull: McCallum, Fiona J.
      – PersonEntity:
          Name:
            NameFull: Gicheru, Nimmo
      – PersonEntity:
          Name:
            NameFull: Kinyanjui, Samson M.
      – PersonEntity:
          Name:
            NameFull: Chitnis, Chetan E.
      – PersonEntity:
          Name:
            NameFull: Fowkes, Freya J.I.
      – PersonEntity:
          Name:
            NameFull: Marsh, Kevin
      – PersonEntity:
          Name:
            NameFull: Beeson, James G.
      – PersonEntity:
          Name:
            NameFull: Lund University, Faculty of Medicine, Department of Clinical Sciences, Lund, Infect@LU, Lunds universitet, Medicinska fakulteten, Institutionen för kliniska vetenskaper, Lund, Infect@LU, Originator
      – PersonEntity:
          Name:
            NameFull: Lund University, Faculty of Medicine, Department of Laboratory Medicine, Division of Clinical Chemistry and Pharmacology, Malaria and Babesia, Lunds universitet, Medicinska fakulteten, Institutionen för laboratoriemedicin, Avdelningen för klinisk kemi och farmakologi, Malaria och Babesia, Originator
      – PersonEntity:
          Name:
            NameFull: Lund University, Faculty of Medicine, Department of Laboratory Medicine, Division of Clinical Chemistry and Pharmacology, Lunds universitet, Medicinska fakulteten, Institutionen för laboratoriemedicin, Avdelningen för klinisk kemi och farmakologi, Originator
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 01
              M: 01
              Type: published
              Y: 2025
          Identifiers:
            – Type: issn-print
              Value: 16643224
            – Type: issn-locals
              Value: SWEPUB_FREE
            – Type: issn-locals
              Value: LU_SWEPUB
          Numbering:
            – Type: volume
              Value: 16
          Titles:
            – TitleFull: Frontiers in Immunology
              Type: main
ResultId 1